🌱 KidneyEnergy.com

← brief for 2026-08-13 · Slowing decline

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of "Ozempic Face".

Article B Peer reviewed Small trial

Key takeaways

GLP-1 drugs cause skin sagging in the face (Ozempic Face), but this may not affect all patients. A study of 100 women found no significant hair or nail changes over 6 months.

Who did this work

Rao S · Midura I · Mangual KPS · Igel LI · Saunders KH · Carter J · Murase JE · Kourosh AS

Source

Article · PubMed, the drug frontier · 2026 Aug 11
https://pubmed.ncbi.nlm.nih.gov/42579223/